Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for Smoking Cessation in Heavy Drinking Smokers
NCT00860028Phase 2Completed
- Sponsor
- Yale University
- Start
- Oct 2008
- Primary completion
- May 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of varenicline in nicotine dependence, alcohol use disorder (AUD), sponsored by Yale University. Started Oct 2008; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependencealcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT00860028.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00860028.